Intellicell Biosciences Inc (fka SVFC)

[Sage7243]

[url][/url][tag]http://www.proactiveinvestors.com.au/companies/news/19356/intellicell-inks-licensing-deal-with-pet-company-paws-19356.html[/tag]

OLD NEWS...But...

Seeing that the FDA put the brakes on other stem cell companies as a drug--but not necessarily Intellicell, is it out of the realm of possibility to consider that the good DR. is thinking about mixing his technology with other meds?



From PetPaws website: PetPaws is now moving to pharmaceutical business.

Is anyone else seeing a possible connection?????????????????


MESA focuses on providing custom compounded non-narcotic, transdermal topical pain medications that are marketed to industrial health physicians and clinics. Many physicians are concerned about prescribing oral controlled narcotic pain medication such as Oxycontin or Vicodin to their patients and are looking for an alternative delivery system. Using only FDA approved medications, MESA has developed a series of topical ointments, in different strengths, that provide the pain relief doctors seek.
Compounding, where the pharmacist individually mixes the drugs, is a long established tradition in the pharmacy industry. 250 million compounding prescriptions are written each year in the U.S. and in 2009, in California alone, pharmacies were paid $340 million by insurance companies representing employers with injured workers.